Avalo Therapeutics to Participate in Upcoming Investor Conferences
Jefferies Global Healthcare Conference 2025, New YorkFireside ChatJune 4, 2025, at 7:35 am ET
Oppenheimer Innovators in I&I Summit, New YorkPanelist: 'Dermatology: AA, HS, PSO'June 25, 2025, at 10am ET
Live webcasts and replays, when available, can be found under "News / Events" in the Investors section of the Avalo Therapeutics website at https://ir.avalotx.com. The archived webcast will be available for replay for at least 30 days.
About Avalo Therapeutics
Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of immune dysregulation. Avalo's lead asset is AVTX-009, an anti-IL-1β mAb, targeting inflammatory diseases. For more information about Avalo, please visit www.avalotx.com.
About AVTX-009
AVTX-009 is a humanized monoclonal antibody (IgG4) that binds to interleukin-1β (IL-1β) with high affinity and neutralizes its activity. IL-1β is a central driver in the inflammatory process. Overproduction or dysregulation of IL-1β is implicated in many autoimmune and inflammatory diseases. IL-1β is a major, validated target for therapeutic intervention. There is evidence that inhibition of IL-1β could be effective in hidradenitis suppurativa and a variety of inflammatory diseases in dermatology, gastroenterology, and rheumatology.
For media and investor inquiriesChristopher Sullivan, CFO Avalo Therapeutics, Inc. ir@avalotx.com 410-803-6793
or
Meru AdvisorsLauren Glaserlglaser@meruadvisors.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
If You'd Invested $100 in Palantir Stock 3 Years Ago, Here's How Much You'd Have Today
Key Points Investors are beginning to see Palantir as more than a niche government contractor. Palantir achieved its first $1 billion quarter in the second quarter. Investors should be wary of Palantir's extremely high valuation. 10 stocks we like better than Palantir Technologies › Artificial intelligence (AI) software company Palantir (NASDAQ: PLTR) has a strong case as the most talked-about stock this year. The success of its AI tools amid the current AI boom has made it one of the more high-profile stocks on the market, and its stock price has followed the hype. Its stock is up 143% year to date through Aug. 14, but the surge started way before now. Had you invested $100 into the stock three years ago (with Aug. 14, 2022, as the starting point), your investment would be worth over $1,850. Calling those returns impressive would undoubtedly be an understatement. What has changed with Palantir's business? Palantir's core business hasn't changed over the past three years, but the surrounding perception seemingly has. For a while, many people viewed Palantir as a niche government contractor, but it is now seen as a company whose software can be used for commercial businesses as well. In the second quarter, Palantir achieved its first $1 billion quarter (up 48% year over year), with its U.S. government and U.S. commercial benefits increasing revenue 53% and 93% year over year, respectively. After such an impressive run over the past three years, the one red flag with Palantir's stock is just how expensive it has become. At the time of this writing, the stock is trading at nearly 135 times its sales, which is, to put it lightly, absurd by even the most lax of standards. Palantir has proven it's a great company and leader in its industry, but if you're investing expecting similar returns over the next three years, you could be in for some disappointment. If you're interested in investing in the company, make sure you approach it with a long-term mindset, and mentally prep yourself for the inevitable volatility. Should you invest $1,000 in Palantir Technologies right now? Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* Now, it's worth noting Stock Advisor's total average return is 1,070% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Stefon Walters has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool has a disclosure policy. If You'd Invested $100 in Palantir Stock 3 Years Ago, Here's How Much You'd Have Today was originally published by The Motley Fool 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
Yahoo
21 minutes ago
- Yahoo
Cantor Fitzgerald Initiates Workday (WDAY) With Overweight Rating, $265 PT
Workday, Inc. (NASDAQ:) is one of the AI Stocks Making Headlines This Week. On August 13, Cantor Fitzgerald initiates coverage on the stock with an Overweight rating and a price target of $265.00. The rating comes as part of a broader research note launching coverage on select Human Capital Management – HCM – names. The firm admits that there are major concerns revolving around Workday's slowing growth, uncertain macroeconomic conditions, and potential AI disruption to the company's seat-based business model. However, the firm is still optimistic about the software enterprise company. A computer engineer seated in front of several connected consoles, illustrating the depth of cloud services offered by the company. 'While we understand the market's concerns regarding WDAY's slowing growth, uncertain macro, and potential AI disruption to WDAY's seat-based model, we think the market has grown too pessimistic. WDAY is a high-quality asset with a strong management team, entrenched competitive position in the enterprise, expanding growth vectors, and latent margin potential. The stock is trading near its all-time low EPS and FCF multiples, which we see as an attractive entry point with a positively skewed risk/reward ratio.' Workday, Inc. (NASDAQ:WDAY) provides enterprise cloud applications. While we acknowledge the potential of WDAY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. 登入存取你的投資組合
Yahoo
21 minutes ago
- Yahoo
Why Morgan Stanley Thinks Apple (AAPL) Shares Could Be Turning the Corner
Apple Inc. (NASDAQ:AAPL) is one of the AI Stocks Making Headlines This Week. One of the most notable analyst calls on Friday, August 15, was for Apple Inc. Morgan Stanley reiterated the stock as 'Overweight' stating that Apple shares appear to be 'turning a corner.' The optimism comes after stronger-than-expected iPhone sales drove an upward revision in September-quarter production plans. 'We are turning more bullish — forward iPhone unit/revenue growth expectations are still relatively muted, many of the same factors that got us bullish last July remain, we're past peak tariff risk…' The firm's Greater China technology hardware team raised their September quarter iPhone build estimate to 54M units, or flat year-over-year, from previous call for 50Million. The raise has been due to better than expected iPhone sell-through in the June quarter that reduced iPhone channel inventory. A busy sidewalk filled with people using Apple devices like iPhones, iPads and Apple Watches. Moreover, iPhone 16, calendar 2025 second half iPhone 17 builds remain unchanged at 80M-85M units, the analysts added. 'We think the Apple story could be turning the corner,' stated the bank, pointing to cited 'elongated replacement cycles,' 'pent-up iPhone demand,' 'structural gross margin tailwinds,' and easing tariff and regulatory headwinds. The firm has an Overweight rating and $240 price target on the stock. With institutions 'more underweight Apple than any other megacap tech stock' and hedge funds 'biased neutral to short,' Morgan Stanley said the company is 'one potential AI partnership away from breaking out.' Apple is a technology company known for its consumer electronics, software, and services. While we acknowledge the potential of AAPL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Sign in to access your portfolio
